| human | Q5 |
| P2798 | Loop ID | 687784 |
| P496 | ORCID iD | 0000-0003-0653-1905 |
| P1153 | Scopus author ID | 56210884900 |
| P69 | educated at | Federal University of Minas Gerais | Q132140 |
| University of Pittsburgh | Q235034 | ||
| Faculty of Medicine of the University of São Paulo | Q8960737 | ||
| P108 | employer | Federal University of Minas Gerais | Q132140 |
| University of Toronto | Q180865 | ||
| University of Texas Health Science Center at Houston | Q7896431 | ||
| Centre for Addiction and Mental Health | Q2945513 | ||
| P734 | family name | Diniz | Q43073361 |
| Diniz | Q43073361 | ||
| Diniz | Q43073361 | ||
| P735 | given name | Breno | Q21285798 |
| Breno | Q21285798 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q36502758 | A Reanalysis of Cognitive-Functional Performance in Older Adults: Investigating the Interaction Between Normal Aging, Mild Cognitive Impairment, Mild Alzheimer's Disease Dementia, and Depression. |
| Q57812962 | A radioenzymatic assay to identify three groups of phospholipase A2 in platelets |
| Q39159267 | ADHD inattentive symptoms mediate the relationship between intelligence and academic performance in children aged 6-14. |
| Q50627251 | APOE ε4 allele is associated with worse performance in memory dimensions of the mini-mental state examination: the Bambuí Cohort Study of Aging. |
| Q57812984 | Alzheimer’s Disease |
| Q40183837 | Antidepressant use and associated factors among the elderly: the Bambuí Project |
| Q38462266 | Bipolar disorder prevalence: a systematic review and meta-analysis of the literature. |
| Q37579433 | Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study. |
| Q91334139 | Brain-enriched MicroRNA-184 is downregulated in older adults with major depressive disorder: A translational study |
| Q51891032 | CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education. |
| Q36933691 | Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia |
| Q39465095 | Circulating Glial-derived neurotrophic factor is reduced in late-life depression |
| Q45300839 | Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. |
| Q51056946 | Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. |
| Q34996931 | Clinical applicability and cutoff values for an unstructured neuropsychological assessment protocol for older adults with low formal education |
| Q46561707 | Cognitive impairment in euthymic older adults with bipolar disorder: a controlled study using cognitive screening tests |
| Q51957609 | Cognitive training increases platelet PLA2 activity in healthy elderly subjects. |
| Q37389846 | Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly. |
| Q46291223 | Combining functional scales and cognitive tests in screening for mild cognitive impairment at a university-based memory clinic in Brazil |
| Q36082991 | Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder |
| Q39504880 | Components of the metabolic syndrome and depressive symptoms in community-dwelling older people: the Bambuí Cohort Aging Study |
| Q46964545 | Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults. |
| Q37932355 | Current pharmacological approaches and perspectives in the treatment of geriatric mood disorders |
| Q48619085 | Decreased Brain-Derived Neurotrophic Factor (BDNF) in Older Adults with Bipolar Disorder: Meaning and Utility? |
| Q57812922 | Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease |
| Q38903903 | Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects |
| Q30252001 | Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: systematic review and meta-analysis. |
| Q57170549 | Depressive symptoms, emotional support and activities of daily living disability onset: 15-year follow-up of the Bambuí (Brazil) Cohort Study of Aging |
| Q91850790 | Diabetes, depressive symptoms, and mortality risk in old age: The role of inflammation |
| Q33777509 | Diagnosis and biomarkers of predementia in Alzheimer's disease. |
| Q51958588 | Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study. |
| Q51135677 | Diagnostic transitions in mild cognitive impairment subtypes. |
| Q92253506 | Diet and Alzheimer's dementia - Nutritional approach to modulate inflammation |
| Q45328463 | Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial |
| Q34268138 | Does lithium prevent Alzheimer's disease? |
| Q48190208 | Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. |
| Q47876260 | Enhanced Molecular Aging in Late-Life Depression: the Senescent-Associated Secretory Phenotype |
| Q90740499 | Epidermal growth factor and fibroblast growth factor-2 circulating levels in elderly with major depressive disorder |
| Q33965567 | Graph analysis of verbal fluency test discriminate between patients with Alzheimer's disease, mild cognitive impairment and normal elderly controls |
| Q28295087 | Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease |
| Q38761579 | History of Bipolar Disorder and the Risk of Dementia: A Systematic Review and Meta-Analysis |
| Q48004778 | Immunological biomarkers associated with brain structure and executive function in late-life depression: exploratory pilot study |
| Q33827449 | Impaired generation of new subcategories and switching in a semantic verbal fluency test in older adults with mild cognitive impairment. |
| Q48153626 | Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease |
| Q47626404 | Increased reward-oriented impulsivity in older bipolar patients: A preliminary study. |
| Q48384376 | Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. |
| Q51853704 | Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. |
| Q38790379 | Inflammatory Response in the CNS: Friend or Foe? |
| Q38790107 | Insomnia and risk of dementia in older adults: Systematic review and meta-analysis |
| Q51857006 | Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. |
| Q53528186 | Is It All about Inflammation? |
| Q36806075 | Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. |
| Q36769080 | Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders |
| Q48267328 | Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes |
| Q44996893 | Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study |
| Q33777999 | Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study |
| Q48676272 | Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression |
| Q38425785 | Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension. |
| Q49031432 | Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study |
| Q38988833 | Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease. |
| Q92756980 | Major depression and enhanced molecular senescence abnormalities in young and middle-aged adults |
| Q96115857 | Mild and moderate cognitive impairment and mortality among Brazilian older adults in long-term follow-up: The Bambui Health Aging Study |
| Q38125621 | Mild cognitive impairment. Part 1: clinical characteristics and predictors of dementia. |
| Q27027319 | Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease |
| Q51873283 | Mild cognitive impairment: cognitive screening or neuropsychological assessment? |
| Q51903669 | Mini-mental State Examination performance in mild cognitive impairment subtypes. |
| Q91999480 | Molecular Senescence Is Associated With White Matter Microstructural Damage in Late-Life Depression |
| Q92019959 | Mood Disorders and Dementia: Time for Action |
| Q33777958 | Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders |
| Q51875074 | Neuropsychological profile of Brazilian older adults with heterogeneous educational backgrounds. |
| Q37652134 | Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies |
| Q51043584 | Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains. |
| Q47605434 | Plasma IL-17A levels in patients with late-life depression. |
| Q37403796 | Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis. |
| Q35828096 | Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression |
| Q48912689 | Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment? |
| Q90552014 | Potential Use of Stem Cells in Mood Disorders |
| Q36772412 | Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial. |
| Q48110387 | Predictors of incidence of clinically significant depressive symptoms in the elderly: 10-year follow-up study of the Bambui cohort study of aging |
| Q51782041 | Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. |
| Q34442861 | Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression. |
| Q53328612 | Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease. |
| Q48493746 | Reduced serum levels of adiponectin in elderly patients with major depression. |
| Q48487954 | Reduced serum nerve growth factor in patients with late-life depression |
| Q37424336 | Regulation of leukocyte tricarboxylic acid cycle in drug-naïve Bipolar Disorder |
| Q57813027 | Renal function outcome after lithium therapy for cognitive decline |
| Q48329873 | Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. |
| Q38945669 | Shared Biologic Pathways Between Alzheimer Disease and Major Depression: A Systematic Review of MicroRNA Expression Studies. |
| Q35865132 | Specific cognitive functions and depressive symptoms as predictors of activities of daily living in older adults with heterogeneous cognitive backgrounds |
| Q90670160 | Stress, Inflammation, and Aging: An Association Beyond Chance |
| Q59358240 | The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review |
| Q91163673 | The Molecular Intersection Between Senescence and Major Depression in the Elderly |
| Q37318123 | The Relationship between Sleep Complaints, Depression, and Executive Functions on Older Adults. |
| Q47765365 | The association between insulin resistance, metabolic variables, and depressive symptoms in Mexican-American elderly: A population-based study |
| Q55514340 | The association between systemic lupus erythematosus and dementia A meta-analysis. |
| Q47594495 | The impact of substance use disorders on clinical outcomes in older-adult psychiatric inpatients |
| Q46333454 | The use of antipsychotics in patients with dementia |
| Q44292423 | To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease |
| Q36381106 | Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer's disease. |
| Q46103248 | Trigeminal Nerve Stimulation (TNS) for Major Depressive Disorder in the Elderly: An Open Label Proof-of-Concept Trial. |
| Q42374732 | Vascular depression consensus report - a critical update. |
| Q33382837 | Voxel-based morphometry in Alzheimer's disease |
| Q50580454 | What can BDNF genotype tell us about our memory? |
| Q50584121 | Working Memory and Cognitive Flexibility Mediates Visuoconstructional Abilities in Older Adults with Heterogeneous Cognitive Ability. |
Search more.